Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparing derivative of tetradotoxin and application for giving up drug habits and easing pain

A technology of tetrodotoxin and derivatives, applied in the direction of drug combination, drug delivery, pill delivery, etc.

Inactive Publication Date: 2006-07-05
林文翰 +2
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] Domestic separation and purification technology of tetrodotoxin (TTX) has matured, and there are related patent protections (patent numbers 02121463.8, 01142658.6, 03138706.3), and there is a patent (02117928. The invention relates to the detoxification and analgesic effects of acetate and citrate of tetrodotoxin, but the acid used in the example is a buffer, and the mol number of acid used in the preparation shows that most TTX has not yet formed a salt, which is the same as that of the present invention. mol salt-forming derivatives have no patent relevance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparing derivative of tetradotoxin and application for giving up drug habits and easing pain
  • Preparing derivative of tetradotoxin and application for giving up drug habits and easing pain
  • Preparing derivative of tetradotoxin and application for giving up drug habits and easing pain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] (1) preparation of tetrodotoxin tartrate:

[0035] Take 100mg of tetrodotoxin (0.31mN), dissolve it in 1.0ml of hot distilled water (40-60°C), add tartaric acid equal to mN, fully ultrasonically vibrate the solution to make the solution in a fully dissolved state, let it rest for a few minutes, and concentrate under reduced pressure to 0.3- 0.5ml, stand still in the refrigerator at -5 to 5°C to form crystals, or directly concentrate under reduced pressure to obtain white crystals.

[0036] (2) preparation of tetrodotoxin maleate:

[0037] Take 100mg of tetrodotoxin (0.31mN), dissolve it in 1.0ml of hot distilled water (40-60°C), add maleic acid equal to mN, fully ultrasonically vibrate to make the solution in a fully dissolved state, stand still for several minutes, and concentrate under reduced pressure to 0.3-0.5ml, stand in a refrigerator at -5 to 5°C to form crystals, or directly concentrate under reduced pressure to obtain white crystals.

[0038] (3) preparation...

Embodiment 2

[0052] Embodiment 2: the analgesic activity of tetrodotoxin tartrate injection

[0053] (1) Tail-flick analgesic experiment in rats

[0054] Rats were randomly divided into four groups, ♂♀ half and half each, 8 rats in each group. They fasted for 12 hours before the experiment and had free access to water. With a constant temperature water bath at 55±1°C as the heat-induced pain source, after the rats were fixed, they were placed in hot water 5 cm above the tip of their tails, and the reaction time from when the tails of the rats entered the water to when they were thrown out of the water was recorded. Select the rats before the test: measure 3 times at intervals of 5 minutes, and select the rats whose tail-flick reaction time is within 3-7s for the test. During the test, 30 minutes after s.c administration, the tail-flick reaction time was measured, and the analgesic effect was defined as the tail-flick reaction time after administration was more than twice that before admi...

Embodiment 3

[0098] Embodiment 3: detoxification activity and dependence test of tetrodotoxin tartrate injection

[0099] The physical dependence test of tetrodotoxin tartrate injection was carried out with 3 kinds of animals and 5 kinds of models. The results showed that two dosage groups of tetrodotoxin tartrate injection were administered to rats and mice s.c. Rats were urged to jump and rats were urged to withdraw from the test. Compared with the morphine control group, the mice did not have a jumping response, and the rats did not appear to have a significant withdrawal response and weight loss; the rat group continued to be administered at a constant dose until the 22nd day. Withdrawal test, observed for 4 days after stopping the drug, no significant weight loss or other withdrawal reactions were observed, and the i.m. Morphine-like withdrawal symptoms and weight loss developed. These results show that the drug does not have physical dependence on opioids, suggesting that the drug w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The derivatives of tetrodotoxin, including the tartarate, maleate, sulfonate, hydrochloride, sulfate, hydroborate, methanseulfonate, acetate and citrate of tetrodotoxin, their forms and preparing processes, and their application in dropping drugs and relaxing pain are disclosed.

Description

Technical field: [0001] The present invention relates to the preparation of various derivatives of tetrodotoxin and the drug detoxification and analgesic application of the preparation. Background technique: [0002] Tetrodotoxin (TTX for short) is a small molecular compound extracted from puffer fish ovary or liver, and its molecular formula is: C 11 h 17 N 3 o 8 , with a molecular weight of 319.27. Biological studies have confirmed that TTX is a specific and strong sodium ion channel blocker, and its clinical application involves the fields of internal medicine, surgery, dermatology and ophthalmology. The toxin has strong analgesic and anesthetic effects, and its analgesic effect is Four times that of Dumerol, the analgesic time can be as long as 2-20 hours, and there is no addiction. There are crude preparations in foreign countries that can replace morphine, Dumerol, atropine and tubocurarine, etc. for the treatment of neuralgia. According to clinical reports, tetro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/529A61K9/08A61K9/19A61K9/20A61K9/48A61P25/04A61P25/36
Inventor 林文翰叶祖光孙蓉
Owner 林文翰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com